Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease
Open Access
- 1 August 2003
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 22 (2) , 280-285
- https://doi.org/10.1183/09031936.03.00012803
Abstract
Despite the fact that muscle weakness is a major problem in chronic obstructive pulmonary disease (COPD), detailed information on myopathological changes at the microscopic level in these patients is scarce, if indeed available at all.Vastus lateralis biopsies of 15 COPD weight-stable patients (body mass index (BMI) 23.9±1.0 kg·m−2; fat-free mass index (FFMI) 17.2±1.7 kg·m−2) and 16 healthy age-matched controls (BMI 26.3±0.8 kg·m−2; FFMI 19.6±2.2 kg·m−2) were evaluated. Histochemistry was used to evaluate myopathological features. Immunohistochemistry was used for the detection of macrophages and leukocytes, and active caspase 3 and terminal deoxynucleotidyl transferase deoxyuridine triphosphate (dUTP) nick-end labelling (TUNEL) as markers of apoptosis.Fatty cell replacement and fibrosis were observed in both groups, the latter being slightly, but significantly, more pronounced in COPD. No differences between COPD and controls were found with respect to central nuclei, necrosis, regeneration, or fibre splitting. Signs of mitochondrial abnormalities were absent and normal numbers of inflammatory cells were found. Active caspase 3 positive myocytes were not observed and no difference was found in the number of TUNEL-positive myonuclei between controls and COPD patients (1.1%versus1.0%, respectively). The cross-sectional area of type-IIX muscle fibres was smaller in COPD than in controls (2,566versus4,248 µm2).Except for the I to IIX shift in fibre types, the selective type-IIX atrophy and a slight accompanying increase in fibrosis and fat cell replacement in chronic obstructive pulmonary disease relative to age-matched controls, no other morphological abnormalities were observed in the muscle biopsies of chronic obstructive pulmonary disease patients. Also, in this group of clinically and weight stable chronic obstructive pulmonary disease patients, apoptosis appeared not to be involved in muscle pathology.Keywords
This publication has 23 references indexed in Scilit:
- EditorialScandinavian Journal of Clinical and Laboratory Investigation, 2008
- Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002
- Inflammatory Response and Body Composition in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failureJournal of Cardiac Failure, 2000
- Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changesHeart, 2000
- Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.Thorax, 1996
- Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease.American Journal of Respiratory and Critical Care Medicine, 1994
- Body composition and exercise performance in patients with chronic obstructive pulmonary disease.Thorax, 1991
- Microangiopathy of endoneurial vessels in hypoxemic chronic obstructive pulmonary disease (COPD)Acta Neuropathologica, 1989
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987